52 Best Neurobiology Startups to Watch in 2025

The Definitive Seedtable Ranking of Neurobiology Startups

We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.

There are 52 start-ups with an aggregate funding of $2.6b. The average funding per company in this subset is $50.6m.

Last update to the database: Feb 18, 2025. See changelog.

See all results for this search

Track over 71,000 companies

Discover
Fast-growing Global startups

Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.

Pricing + Sign up

3

Funding Rounds

$34.0m

Money raised

Paradromics is an Austin, Texas-based company developing a high-volume bidirectional data streaming capabilities between brains and computers.

Key people:

3

Funding Rounds

$125.0m

Money raised

Synchron, Inc. is a technology company building implantable neural interface solutions, including endovascular brain-computer interface.

3

Funding Rounds

$145.0m

Money raised

Cala Health offers bioelectronic medicines, medical devices, and neurotherapeutics for managing chronic health conditions.

Key people:

5

Funding Rounds

$134.1m

Money raised

Verge Genomics is a company focused on the discovery and development of drugs for the treatment of neurodegenerative diseases with the use of machine learning and computational genomics.

Key people:

2

Funding Rounds

$25.0m

Money raised

Reverie Labs is a drug dicovery company that uses machine learning founded by Jonah Kallenbach.

Location:

Key people:

3

Funding Rounds

$15.1m

Money raised

CB Therapeutics is a biotechnology company focused on the biosynthetic production of cannabinoids from sugar.

Location:

Key people:

1

Funding Rounds

$44.0m

Money raised

Annexon Biosciences is a South San Francisco, California-based biotechnology company working on discovering and developing therapeutics for neurodegenerative and autoimmune disorders.

2

Funding Rounds

$21.2m

Money raised

Q-State is a therapeutics company that facilitates programs for the treatment of epilepsy, pains and other diseases of the central nervous system.

3

Funding Rounds

$26.3m

Money raised

Creating a New Gold Standard in Brain Health With Precision Neurology.

Location:

Key people:

4

Funding Rounds

$160.0m

Money raised

Mindstrong Health is a neuroscience precision therapy company founded in 2014 by Paul Dagum.

Key people:

2

Funding Rounds

$100.0m

Money raised

Delix Therapeutics is a CNS-focused drug discovery company.

Location:

2

Funding Rounds

$20.0m

Money raised

Bionaut Labs develops precision medicine treatments for CNS disorders.

Location:

Key people:

2

Funding Rounds

$140.0m

Money raised

Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.

13

Funding Rounds

$147.7m

Money raised

Minoryx Therapeutics is a small Molecules for Rare Diseases founded in 2011.

4

Funding Rounds

$62.7m

Money raised

CODA Biotherapeutics, Inc. is a biopharmaceutical company that develops an innovative gene therapy platform for treating neurological disorders and diseases.

4

Funding Rounds

$34.6m

Money raised

Rune Labs is a software and data platform for neuromodulation founded in 2018 by Brian Pepin.

Location:

Key people:

4

Funding Rounds

$17.5m

Money raised

Quadrant Biosciences Inc is a Syracuse, New York-based medical diagnostics company developing solutions for head injury assessment and autism detection founded in 2011 by Richard Uhlig.

Key people:

2

Funding Rounds

$55.2m

Money raised

Xalud Therapeutics is a neuropathic pain therapies.

1

Funding Rounds

$13.0m

Money raised

Chronos is an Oxford-based biotechnology company operating a semi-virtual R&D model to develop a portfolio of therapies in degenerative and behavioral brain diseases.

1

Funding Rounds

$83.0m

Money raised

Nitrase Therapeutics is a Brisbane, California-based company offering a biopharmaceutical platform, Nitrome, designed to offer therapies against a broad variety of diseases.

2

Funding Rounds

$6.0m

Money raised

Tetra Therapeutics is a Grand Rapids, Michigan-based biotechnology company developing drugs for brain-related diseases.

1

Funding Rounds

$55.0m

Money raised

Linus Health is a company founded in 2019.

3

Funding Rounds

$514.0k

Money raised

Brain Scientific is a healthcare company that offers modern solutions to the neurology industry.

2

Funding Rounds

$25.0m

Money raised

Stalicla is a Geneva-based company developing a drug development platform for neurodevelopmental disorders.

3

Funding Rounds

$117.0m

Money raised

Neurostimulation device

2

Funding Rounds

$180.0m

Money raised

Neuron23 is an AI-drug discovery founded in 2018 by Adam Knight.

1

Funding Rounds

$26.0m

Money raised

A biopharmaceutical company developing therapiesfor the treatment of central nervous system disorders

2

Funding Rounds

$20.5m

Money raised

RedPin Therapeutics a preclinical stage gene therapy company based in New York City.

2

Funding Rounds

$30.0m

Money raised

Coya Therapeutics develops treatments that target regulatory T cells, or Tregs, to treat Alzheimer's and ALS.

3

Funding Rounds

$33.6m

Money raised

Amyl Therapeutics unique technology offers a curative solution for all forms of amyloid mediated diseases

Location:

Key people:

1

Funding Rounds

$15.0m

Money raised

Noveome Biotherapeutics, Inc. is a biotechnology research company focused on therapies for the regenerative repair of inflamed or damaged tissue.

Location:

4

Funding Rounds

$12.3m

Money raised

Alpha Cognition is a clinical stage, biopharmaceutical company developing treatments for neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis (ALS).

1

Funding Rounds

$18.0m

Money raised

CuraSen Therapeutics, Inc. is a privately funded biopharmaceutical company pursuing development of novel treatments for neurodegenerative diseases, including Parkinson’s disease and Alzheimer’s disease, as well as several orphan indications

Location:

Key people:

2

Funding Rounds

$4.9m

Money raised

A company developing treatments for central nervous system related diseases and injuries

2

Funding Rounds

$80.0m

Money raised

Cadent Therapeutics was a Cambridge, Massachusetts-based precision neuroscience company developing drugs for the treatment of psychiatric diseases The company was acquired by Novartis in December 2020.

2

Funding Rounds

$9.0m

Money raised

TheraVida is a company developing therapies for hyperhidrosis.

1

Funding Rounds

$6.6m

Money raised

A medical technology companythat develops therapies for acute ischemic stroke and other vascular disorders

3

Funding Rounds

$257.5m

Money raised

A company deveoping treatments for Alzheimer's disease and other neurological conditions

2

Funding Rounds

$12.0m

Money raised

Q Therapeutics is a CNS Therapies.

2

Funding Rounds

$10.0m

Money raised

A biopharmaceutical company developing biologics and small molecules for treating central nervous system conditions

2

Funding Rounds

$2.7m

Money raised

Cognos Therapeutics creates technologies to advance the diagnosis and treatment of neuropathic diseases.

1

Funding Rounds

$1.4m

Money raised

A company developing diagnostic medical devices for the detection of cerebrospinal fluid leaks and early-stage prostate cancer

1

Funding Rounds

Vivid Genomics is a San Diego-based drug development company focused on neurodegenerative diseases.

2

Funding Rounds

$82.5m

Money raised

MycoMedica Life Sciences, PBC is a company founded in 2021.

2

Funding Rounds

$64.0m

Money raised

Engrail Therapeutics is a treatments for Life-Limiting Diseases.

2

Funding Rounds

$5.2m

Money raised

Circular Genomics Inc. is an Albuquerque, New Mexico-based company founded in 2021.

1

Funding Rounds

$50.0m

Money raised

Retrotope Inc. is a Los Altos, California-based company founded in 2006.

1

Funding Rounds

$63.0m

Money raised

E-Scape Bio is a South San Francisco, California-based company founded in 2015.

1

Funding Rounds

$5.0m

Money raised

MedGenesis Therapeutix is a neurologic Treatment - 'Convection Enhanced Delivery.

1

Funding Rounds

$17.9m

Money raised

Magnolia Neurosciences is a Seattle-based company founded in 2018.

1

Funding Rounds

$5.0m

Money raised

Amylyx is a Cambridge, Massachusetts-based company.

1

Funding Rounds

$12.0m

Money raised

Cleave Therapeutics is a protein degradation inhibitors.

Sign up to access our full database

Enter your email and get access to 71,000 + technology companies you can partner with.

Join 29000+ founders, operators, and investors.